Is FormFactor (FORM) Expensive Following Its Russell Index Reshuffle?
FormFactor, Inc. FORM | 0.00 |
Index reshuffle puts FormFactor in front of larger-cap investors
FormFactor (FORM) has shifted out of several Russell small cap and value indices and into the Russell 1000, Russell Midcap and related growth benchmarks, a reshuffle that can influence passive fund flows and trading activity.
FormFactor's share price has pulled back sharply in the very short term, with a 1-day share price return down 12.11% and a 7-day share price return down 16.55%. Momentum over longer horizons remains strong, with a 120.88% year-to-date share price return and a 1-year total shareholder return of 279.95%, indicating that longer term holders have seen substantial gains as the stock transitions into larger cap indices.
If the recent index moves have you thinking about where else growth and risk are being repriced, it could be a good time to scan 51 AI infrastructure stocks
After such a sharp pullback following very strong 1-year and year-to-date returns, the key question for FormFactor is whether recent weakness hints at mispricing or if the market is already looking ahead and fully accounting for future growth.
Most Popular Narrative: 28.7% Overvalued
FormFactor last closed at $130.74, while the most widely followed narrative sets fair value at $101.56. This indicates a meaningful valuation gap driven by specific growth and profitability assumptions that sit behind those numbers.
Accelerating adoption of generative AI, high-performance computing, and HBM DRAM in data centers is driving substantial increases in test complexity and intensity. FormFactor's differentiated probe cards and early leadership in HBM4 chiplet testing position the company to benefit from higher ASPs and revenue growth as these markets scale. (Impacts: Revenue, potential margin improvement)
Read the complete narrative. Read the complete narrative.
Analysts are incorporating assumptions of brisk revenue expansion, a sizeable lift in profit margins, and a rich future earnings multiple to justify that fair value. Want to see how those moving parts combine to support such a premium price tag, and what kind of earnings path they are implicitly backing in the AI test market?
Result: Fair Value of $101.56 (OVERVALUED)
However, FormFactor still faces pressure from customer concentration and potential margin strain from tariffs and higher operating costs, which could challenge the optimistic growth narrative.
Next Steps
With FormFactor's mixed signals on valuation and fundamentals, do you want to rely on the crowd or test the thesis yourself quickly and clearly? Take a closer look at the balance between upside potential and the issues that could matter most by weighing 2 key rewards and 3 important warning signs
Looking for more FormFactor sized investment ideas?
If you like FormFactor but do not want to rest everything on one stock, you can use focused stock lists to spot fresh ideas before the crowd catches on.
- Target higher potential returns by scanning 21 elite penny stocks with strong financials that already show solid financial foundations instead of relying on hype alone.
- Strengthen your core portfolio by reviewing 44 high quality undervalued stocks where quality businesses trade at prices that may not fully reflect their fundamentals.
- Prioritise resilience by assessing 69 resilient stocks with low risk scores that combine lower risk scores with fundamentals many investors overlook until it is too late.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
